share_log

Exane BNP Paribas Initiates Coverage On Stem With Neutral Rating, Announces Price Target of $5

Benzinga ·  Oct 20, 2023 06:55

Exane BNP Paribas analyst Moses Sutton initiates coverage on Stem (NYSE:STEM) with a Neutral rating and announces Price Target of $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment